mebendazole has been researched along with Colitis Gravis in 3 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mebendazole (MBZ) is an efficacious anthelmintic with known anti-inflammatory and fibrinolytic properties." | 5.72 | Mebendazole, an anti-helminth drug, suppresses inflammation, oxidative stress and injury in a mouse model of ulcerative colitis. ( Ahadi, M; Asgharzadeh, F; Askarnia-Faal, MM; Avan, A; Eskandari, M; Ferns, G; Gharib, M; Hassanian, SM; Khazaei, M; Naghibzadeh, N; Naimi, H; Ryzhikov, M; Soleimani, A; Vossoughinia, H, 2022) |
| "Mebendazole (MBZ) is an efficacious anthelmintic with known anti-inflammatory and fibrinolytic properties." | 1.72 | Mebendazole, an anti-helminth drug, suppresses inflammation, oxidative stress and injury in a mouse model of ulcerative colitis. ( Ahadi, M; Asgharzadeh, F; Askarnia-Faal, MM; Avan, A; Eskandari, M; Ferns, G; Gharib, M; Hassanian, SM; Khazaei, M; Naghibzadeh, N; Naimi, H; Ryzhikov, M; Soleimani, A; Vossoughinia, H, 2022) |
| "Based on a population-based analysis, enterobiasis does not reduce risk for asthma, type 1 diabetes, arthritis, or inflammatory bowel disease." | 1.38 | Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study. ( Bager, P; Melbye, M; Vinkel Hansen, A; Wohlfahrt, J, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Eskandari, M | 1 |
| Asgharzadeh, F | 1 |
| Askarnia-Faal, MM | 1 |
| Naimi, H | 1 |
| Avan, A | 1 |
| Ahadi, M | 1 |
| Vossoughinia, H | 1 |
| Gharib, M | 1 |
| Soleimani, A | 1 |
| Naghibzadeh, N | 1 |
| Ferns, G | 1 |
| Ryzhikov, M | 1 |
| Khazaei, M | 1 |
| Hassanian, SM | 1 |
| Agrawal, M | 1 |
| Allin, KH | 1 |
| Iversen, AT | 1 |
| Mehandru, S | 1 |
| Colombel, JF | 1 |
| Jess, T | 1 |
| Bager, P | 1 |
| Vinkel Hansen, A | 1 |
| Wohlfahrt, J | 1 |
| Melbye, M | 1 |
3 other studies available for mebendazole and Colitis Gravis
| Article | Year |
|---|---|
Mebendazole, an anti-helminth drug, suppresses inflammation, oxidative stress and injury in a mouse model of ulcerative colitis.
Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Fibrosis; Hum | 2022 |
Early-Life Mebendazole Exposure Increases the Risk of Adult-Onset Ulcerative Colitis: A Population-Based Cohort Study.
Topics: Adolescent; Adult; Child; Child, Preschool; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Huma | 2022 |
Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study.
Topics: Adolescent; Animals; Antinematodal Agents; Arthritis, Juvenile; Asthma; Child; Child, Preschool; Coh | 2012 |